Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis

Clinical and Vaccine Immunology

Volumn 17, Issue 10, 2010, Pages 1500-1506

  Komine Aizawa, Shihoko ^a,e   Yamazaki, Toshio ^b   Yamazaki, Tsuyoshi ^h   Hattori, Shin Ichiro ^a,i   Miyamoto, Yuji ^c   Yamamoto, Naoki ^a,j   Haga, Shinji ^d   Sugitani, Masahiko ^f   Honda, Mitsuo ^a,e   Hayakawa, Satoshi ^a,e   Yamamoto, Saburo ^g  

^a AIDS Research Center   (Japan)

^b Division of Biosafety Control and Research   (Japan)

^c Research Center   (Japan)

^d Department of Bacteriology ^*  (Japan)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^f Chugai Pharmaceutical Chuo ku   (Japan)

^g NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h TOKAI UNIVERSITY   (Japan)

ⁱ KUMAMOTO UNIVERSITY   (Japan)

^j NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GUINEA PIG; HISTOPATHOLOGY; INFECTION PREVENTION; INTERFERON PRODUCTION; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

AGE FACTORS; ANIMALS; FEMALE; GUINEA PIGS; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; LYMPHOCYTES; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION;

EID: 77957884751     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00190-10     Document Type: Article

References (42)

1. Aktas, E., F. Ciftci, S. Bilgic, O. Sezer, E. Bozkanat, O. Deniz, U. Citici, and G. Deniz. 2009. Peripheral immune response in pulmonary tuberculosis. Scand. J. Immunol. 70:300-308.
2. Andersen, P. 2007. Tuberculosis vaccines - an update. Nat. Rev. Microbiol. 5:484-487.
3. Aronson, N. E., M. Santosham, G. W. Comstock, R. S. Howard, L. H. Moulton, E. R. Rhoades, and L. H. Harrison. 2004. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. JAMA 291:2086-2091.
4. Babu, S., S. Q. Bhat, N. P. Kumar, S. Jayantasri, S. Rukmani, P. Kumaran, P. G. Gopi, C. Kolappan, V. Kumaraswami, and T. B. Nutman. 2009. Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J. Infect. Dis. 200:288-298.
5. Barreto, M. L., S. M. Pereira, and A. A. Ferreira. 2006. BCG vaccine: efficacy and indications for vaccination and revaccination. J. Pediatr. (Rio J.) 82: S45-S54.
6. Black, G. F., R. E. Weir, S. Floyd, L. Bliss, D. K. Warndorff, A. C. Crampin, B. Ngwira, L. Sichali, B. Nazareth, J. M. Blackwell, K. Branson, S. D. Chaguluka, L. Donovan, E. Jarman, E. King, P. E. Fine, and H. M. Dockrell. 2002. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359:1393-1401.
7. Brewer, T. F. 2000. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin. Infect. Dis. 31(Suppl 3):S64-S67.
8. Cabinet Office, Government of Japan. 2008. Annual report on the aging society. http://www8.cao.go.jp/kourei/english/annualreport/index-wh.html.
9. Cooper, A. M., J. E. Callahan, J. P. Griffin, A. D. Roberts, and I. M. Orme. 1995. Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect. Immun. 63:3259-3265.
10. Cooper, A. M., and S. A. Khader. 2008. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226:191-204.
11. Feng, C. G., D. Jankovic, M. Kullberg, A. Cheever, C. A. Scanga, S. Hieny, P. Caspar, G. S. Yap, and A. Sher. 2005. Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J. Immunol. 174:4185-4192.
12. Fjällbrant, H., M. Ridell, and L. O. Larsson. 2007. Primary vaccination and revaccination of young adults with BCG: a study using immunological markers. Scand. J. Infect. Dis. 39:792-798.
13. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
14. Friedman, A., J. Turner, and B. Szomolay. 2008. A model on the influence of age on immunity to infection with Mycobacterium tuberculosis. Exp. Gerontol. 43:275-285.
15. Gupta, U. D., and V. M. Katoch. 2005. Animal models of tuberculosis. Tuberculosis (Edinb.) 85:277-293.
16. Jeevan, A., T. Yoshimura, K. E. Lee, and D. N. McMurray. 2003. Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination. Infect. Immun. 71:354-364.
17. Jeon, C. Y., and M. B. Murray. 2008. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 5:e152.
18. Kanekiyo, M., K. Matsuo, M. Hamatake, T. Hamano, T. Ohsu, S. Matsumoto, T. Yamada, S. Yamazaki, A. Hasegawa, N. Yamamoto, and M. Honda. 2005. Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette- Guérin expressing human immunodeficiency virus type 1 Gag. J. Virol. 79:8716-8723. (Pubitemid 40934782)
19. Karonga Prevention Trial Group. 1996. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 348:17-24.
20. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377.
21. Khader, S. A., and A. M. Cooper. 2008. IL-23 and IL-17 in tuberculosis. Cytokine 41:79-83.
22. Khader, S. A., S. Partida-Sanchez, G. Bell, D. M. Jelley-Gibbs, S. Swain, J. E. Pearl, N. Ghilardi, F. J. Desauvage, F. E. Lund, and A. M. Cooper. 2006. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203:1805-1815.
23. Ly, L. H., M. I. Russell, and D. N. McMurray. 2008. Cytokine profiles in primary and secondary pulmonary granulomas of guinea pigs with tuberculosis. Am. J. Respir. Cell Mol. Biol. 38:455-462.
24. Ly, L. H., M. I. Russell, and D. N. McMurray. 2007. Microdissection of the cytokine milieu of pulmonary granulomas from tuberculous guinea pigs. Cell. Microbiol. 9:1127-1136.
25. McMurray, D. N. 2001. Disease model: pulmonary tuberculosis. Trends Mol. Med. 7:135-137.
26. McMurray, D. N., S. S. Allen, A. Jeevan, T. Lasco, H. Cho, T. Skwor, T. Yamamoto, C. McFarland, and T. Yoshimura. 2005. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis. Tuberculosis (Edinb.) 85:295-301.
27. Orme, I. M., J. P. Griffin, A. D. Roberts, and D. N. Ernst. 1993. Evidence for a defective accumulation of protective T cells in old mice infected with Mycobacterium tuberculosis. Cell. Immunol. 147:222-229.
28. Rahman, M., M. Sekimoto, K. Hira, H. Koyama, Y. Imanaka, and T. Fukui. 2002. Is bacillus Calmette-Guérin revaccination necessary for Japanese children? Prev. Med. 35:70-77.
29. Research Institute of Tuberculosis/JATA, Tuberculosis Surveillance Center. 2009. Annual reports 2008. http://jata.or.jp/rit/ekigaku/en/index.php? annual%20report.
30. Ritz, N., W. A. Hanekom, R. Robins-Browne, W. J. Britton, and N. Curtis. 2008. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol. Rev. 32:821-841.
31. Robinson, C. M., and G. J. Nau. 2008. Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis. J. Infect. Dis. 198:359-366.
32. Rodrigues, L. C., S. M. Pereira, S. S. Cunha, B. Genser, M. Y. Ichihara, S. C. de Brito, M. A. Hijjar, I. Dourado, A. A. Cruz, C. Sant'Anna, A. L. Bierrenbach, and M. L. Barreto. 2005. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 366:1290-1295.
33. Soysal, A., K. A. Millington, M. Bakir, D. Dosanjh, Y. Aslan, J. J. Deeks, S. Efe, I. Staveley, K. Ewer, and A. Lalvani. 2005. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 366:1443-1451. (Pubitemid 41483810)
34. Trunz, B. B., P. Fine, and C. Dye. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367:1173-1180.
35. Turner, J., A. A. Frank, and I. M. Orme. 2002. Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells. Infect. Immun. 70:4628-4637.
36. Vesosky, B., D. K. Flaherty, E. K. Rottinghaus, G. L. Beamer, and J. Turner. 2006. Age dependent increase in early resistance of mice to Mycobacterium tuberculosis is associated with an increase in CD8 T cells that are capable of antigen independent IFN-γ production. Exp. Gerontol. 41:1185-1194.
37. Vesosky, B., D. K. Flaherty, and J. Turner. 2006. Th1 cytokines facilitate CD8-T-cell-mediated early resistance to infection with Mycobacterium tuberculosis in old mice. Infect. Immun. 74:3314-3324.
38. Vesosky, B., E. K. Rottinghaus, C. Davis, and J. Turner. 2009. CD8 T cells in old mice contribute to the innate immune response to Mycobacterium tuberculosis via interleukin-12p70-dependent and antigen-independent production of gamma interferon. Infect. Immun. 77:3355-3363.
39. Vesosky, B., and J. Turner. 2005. The influence of age on immunity to infection with Mycobacterium tuberculosis. Immunol. Rev. 205:229-243.
40. Walker, V., G. Selby, and I. Wacogne. 2006. Does neonatal BCG vaccination protect against tuberculous meningitis? Arch. Dis. Child. 91:789-791.
41. Yamamoto, S., and T. Yamamoto. 2007. Historical review of BCG vaccine in Japan. Jpn. J. Infect. Dis. 60:331-336.
42. Yamamoto, T., T. M. Lasco, K. Uchida, Y. Goto, A. Jeevan, C. McFarland, L. Ly, S. Yamamoto, and D. N. McMurray. 2007. Mycobacterium bovis BCG vaccination modulates TNF-α production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs. Tuberculosis (Edinb.) 87:155-165.